輸入代號或公司名稱後按 Enter
3176

基亞

+1.55 (+4.43%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
36.502,843成交張數本益比3.44股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度資產總額(億)母公司權益(億)負債比率流動比率每股淨值ROE(近四季)ROA(近四季)營業現金流(億)自由現金流(億)
2026Q2691531.8%5.6410.60-15.9%-3.8%-0.9-1.0
2026Q1691532.1%5.4110.73-16.6%-3.9%-0.9-1.9
2025Q4621523.7%4.6811.12-7.0%-1.7%1.41.3
2025Q3631622.8%5.1211.77-6.4%-1.6%-0.2-0.7
2025Q2651723.5%4.4312.14-4.5%-1.1%-0.5-0.6
2025Q1661723.0%4.6912.11-1.6%-0.4%-0.3-0.3
2024Q4671624.9%3.9611.36-12.9%-2.7%1.61.5
2024Q3671724.0%4.0712.06-23.3%-5.2%-0.3-0.4
2024Q2681725.1%3.6012.03-24.2%-5.4%-0.8-0.9
2024Q1841641.2%1.9711.17-30.8%-6.1%-0.1-0.2
2023Q4851641.4%2.0511.42-29.6%-6.1%-0.0-0.1
2023Q3911937.3%2.3013.38-27.0%-6.0%-0.9-1.0
2023Q2931937.4%2.2913.64-30.0%-6.6%-4.2-4.2
2023Q1952035.3%7.0714.13-31.0%-7.8%0.1-0.1
2022Q41002235.2%6.4015.73-29.5%-7.4%0.80.7
2022Q31072530.7%8.6618.24-10.4%-2.7%-5.2-5.3
2022Q21102531.7%7.2518.11-2.8%-0.7%-6.0-6.2
2022Q1822520.8%5.2117.77-3.2%-1.0%-1.0-1.1
2021Q4822421.6%4.6217.18-2.5%-0.7%9.58.7
2021Q3742128.4%2.9715.42-10.9%-3.2%-2.2-2.4
2021Q2702034.9%2.1714.08-22.4%-6.3%-0.6-0.8
2021Q1621927.0%3.1313.59-20.4%-5.9%-1.5-1.6
2020Q4621826.9%3.2413.06-21.3%-6.2%-1.7-1.9
2020Q3491444.2%1.5110.35-28.1%-8.8%-2.0-2.1
2020Q2481343.8%1.499.70-26.5%-8.1%-2.0-2.2
2020Q1501442.5%1.629.82-16.8%-5.0%-1.1-1.5
2019Q4481444.4%1.419.79-17.6%-5.4%-1.5-1.9
2019Q3451540.4%1.6810.80-19.6%-6.8%-0.4-0.7
2019Q2481639.2%2.1311.43-19.3%-6.8%-1.1-1.2
2019Q1471539.6%2.4010.90-28.8%-10.3%-2.6-2.8
2018Q4461536.0%2.3411.08-26.2%-9.4%-1.4-1.7
2018Q3481731.4%3.3012.47-21.5%-8.3%-1.2-1.4
2018Q2491830.1%3.8213.19-20.8%-8.3%-1.1-1.6
2018Q1461833.9%2.0012.95-20.8%-8.7%-1.5-1.6
2017Q4481834.4%2.0713.25-23.1%-9.7%-1.2-1.5
2017Q3492029.5%2.4214.33-20.3%-9.0%-1.1-1.3
2017Q2472030.4%2.1614.45-22.2%-10.3%-0.8-0.9
2017Q1462127.1%2.2215.10-24.5%-11.8%-0.9-1.3
2016Q4482226.6%2.4715.87-1.3-2.1
2016Q3482322.2%4.0916.65-1.4-2.2